Mapping spatial heterogeneity in the tumor microenvironment: A new era for digital pathology

Laboratory Investigation

Volumn 95, Issue 4, 2015, Pages 377-384

  Heindl, Andreas ^a   Nawaz, Sidra ^a   Yuan, Yinyin ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BIOINFORMATICS; BLOOD VESSEL; BREAST CANCER; CANCER DIAGNOSIS; DIGITAL PATHOLOGY; GENOMICS; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; KIDNEY CARCINOMA; LYMPH VESSEL; METABOLOMICS; MOLECULAR PATHOLOGY; MOUTH SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS; SOLID TUMOR; STATISTICAL ANALYSIS; STROMA CELL; TRANSCRIPTOMICS; TUMOR CELL; TUMOR MICROENVIRONMENT; UTERINE CERVIX CANCER; ANIMAL; BIOLOGY; CYTOLOGY; MOLECULAR DIAGNOSIS; MOUSE; NEOPLASMS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; COMPUTATIONAL BIOLOGY; CYTOLOGICAL TECHNIQUES; HUMANS; MICE; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84926322575     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.155     Document Type: Article

References (61)

1. Gurcan MN, Boucheron LE, Can A, et al. Histopathological image analysis: a review. IEEE Rev Biomed Eng 2009;2:147-171.
2. Kothari S, Phan JH, Stokes TH, et al. Pathology imaging informatics for quantitative analysis of whole-slide images. J Am Med Inform Assoc 2013;20:1099-1108.
3. Tabesh A, Teverovskiy M, Pang HY, et al. Multifeature prostate cancer diagnosis and Gleason grading of histological images. IEEE Trans Med Imaging 2007;26:1366-1378.
4. Doyle S, Feldman M, Tomaszewski J, et al. A boosted Bayesian multiresolution classifier for prostate cancer detection from digitized needle biopsies. IEEE Trans Biomed Eng 2012;59:1205-1218.
5. Roux L, Racoceanu D, Lomenie N, et al. Mitosis detection in breast cancer histological images An ICPR 2012 contest. J Pathol Inform 2013;4:8.
6. Khan AM, Eldaly H, Rajpoot NM. A gamma-gaussian mixture model for detection of mitotic cells in breast cancer histopathology images. J Pathol Inform 2013;4:11.
7. Beck AH, Sangoi AR, Leung S, et al. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med 2011;3108ra113.
8. Lewis Jr JS, Ali S, Luo J, et al. A quantitative histomorphometric classifier (QuHbIC) identifies aggressive versus indolent p16-positive oropharyngeal squamous cell carcinoma. Am J Surg Pathol 2014;38: 128-137.
9. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012;21: 309-322.
10. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013;501:346-354.
11. Davnall F, Yip CS, Ljungqvist G, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 2012;3:573-589.
12. Ganeshan B, Miles KA. Quantifying tumour heterogeneity with CT. Cancer Imaging 2013;13:140-149.
13. Gillies RJ, Verduzco D, Gatenby RA. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer 2012;12:487-493.
14. Mahmoud SMA, Paish EC, Powe DG, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011;29:1949-1955.
15. Loi S, Sirtaine N, Piette F, et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. J Clin Oncol 2013;31:860-867.
16. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;348:203-213.
17. Denkert C, Loibl S, Noske A, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010;28:105-113.
18. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-1964.
19. Kruger JM, Wemmert C, Sternberger L, et al. Combat or surveillance? Evaluation of the heterogeneous inflammatory breast cancer microenvironment. J Pathol 2013;229:569-578.
20. Tan KL, Scott DW, Hong F, et al. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial. Blood 2012;120:3280-3287.
21. Varghese F, Bukhari AB, Malhotra R, et al. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One 2014;9:e96801.
22. Tuominen VJ, Ruotoistenmaki S, Viitanen A, et al. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67. Breast Cancer Res 2010;12:R56.
23. Paolino M, Choidas A, Wallner S, et al. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature 2014;507:508-512.
24. Wille C, Kohler C, Armacki M, et al. Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases. Mol Biol Cell 2014;25:324-336.
25. Elkabets M, Gifford AM, Scheel C, et al. Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest 2011;121:784-799.
26. Mikalsen LTG, Dhakal HP, Bruland OS, et al. Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections. Anticancer Res 2011;31: 4053-4060.
27. Goddard JC, Sutton CD, Furness PN, et al. A computer image analysis system for microvessel density measurement in solid tumours. Angiogenesis 2002;5:15-20.
28. Kim NT, Elie N, Plancoulaine B, et al. An original approach for quantification of blood vessels on the whole tumour section. Anal Cell Pathol 2003;25:63-75.
29. Galon J, Mlecnik B, Bindea G, et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol 2014;232:199-209.
30. Fridman WH, Pages F, Sautes-Fridman C, et al. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012;12:298-306.
31. Calabró A, Beissbarth T, Kuner R, et al. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Res Treat 2009;116:69-77.
32. Ascierto ML, Kmieciak M, Idowu MO, et al. A signature of immune function genes associated with recurrence-free survival in breast cancer patients. Breast Cancer Res Treat 2012;131:871-880.
33. Rody A, Holtrich U, Pusztai L, et al. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res 2009;11:R15.
34. Gu-Trantien C, Loi S, Garaud S, et al. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest 2013;123:2873-2892.
35. Janowczyk A, Chandran S, Madabhushi A. Quantifying local heterogeneity via morphologic scale: Distinguishing tumoral from stromal regions. J Pathol Inform 2013;4(Suppl):S8.
36. Yuan Y, Failmezger H, Rueda OM, et al. Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci Transl Med 2012;4:157ra143.
37. Basavanhally AN, Ganesan S, Agner S, et al. Computerized imagebased detection and grading of lymphocytic infiltration in HER2+ breast cancer histopathology. IEEE Trans Biomed Eng 2010;57:642-653.
38. Yuan Y. Modelling the spatial and molecular heterogeneity of lymphocytic infiltration in triple-negative breast cancer. J R Soc Interface 2014 (in press).
39. Andre F, Dieci MV, Dubsky P, et al. Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer. Clin Cancer Res 2013;19:28-33.
40. Setiadi AF, Ray NC, Kohrt HE, et al. Quantitative, architectural analysis of immune cell subsets in tumor-draining lymph nodes from breast cancer patients and healthy lymph nodes. PLoS One 2010;5:e12420.
41. Besag J. Comments on Ripley's paper. J R Stat Soc Series B Stat Methodol 1977;39:193-195.
42. Holmes S, Kapelner A, Lee PP. An interactive java statistical image segmentation system: Gemident. J Stat Softw 2009;30:i10.
43. Ripley BD. The Second-Order Analysis of Stationary Point Processes. J Appl Probab 1976;13:255-266.
44. MacQueen J (ed)Some methods for classification and analysis of multivariate observations. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, Vol. 1 University of California Press: Berkeley, Calif, CA, USA, 1967.
45. Mansfield J, Nelson L, van der Loos C, et al. Abstract C286: phenotyping TILs in situ: automated enumeration of Tregs and Tacts in solid tumors. Mol Cancer Ther 2013;12(Suppl 11):C286.
46. Feichtenbeiner A, Haas M, Buttner M, et al. Critical role of spatial interaction between CD8(+) and Foxp3(+) cells in human gastric cancer: the distance matters. Cancer Immunol Immunother 2014; 63:111-119.
47. Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013;39:782-795.
48. Chang AY, Bhattacharya N, Mu J, et al. Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients. J Transl Med 2013;11:242.
49. Singh S, Raman S, Caserta E, Leone G, Ostrowski M, Rittscher J, Machiraju R. Analysis of spatial variation of nuclear morphology in tissue microenvironments. Biomedical Imaging: From Nano to Macro, 2010 IEEE International Symposium on, vol., no., pp 1293-1296, 14-17 April 2010; doi: 10.1109/ISBI.2010.5490233.
50. van Wyk HC, Roxburgh CS, Horgan PG, et al. The detection and role of lymphatic and blood vessel invasion in predicting survival in patients with node negative operable primary colorectal cancer. Crit Rev Oncol Hematol 2014;90:77-90.
51. Gujam FJ, Going JJ, Edwards J, et al. The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer. Crit Rev Oncol Hematol 2014;89:231-241.
52. Sleeman JP, Thiele W. Tumor metastasis and the lymphatic vasculature. Int J Cancer 2009;125:2747-2756.
53. Balsat C, Blacher S, Signolle N, et al. Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description. ISRN Obstet Gynecol 2011;2011:354861.
54. Balsat C, Signolle N, Goffin F, et al. Improved computer-assisted analysis of the global lymphatic network in human cervical tissues. Mod Pathol 2014;27:887-898.
55. Singanamalli A, Sparks R, Rusu M, Shih N, Ziober A, Tomaszewski J, Rosen M, Feldman M, Madabhushi A. Identifying in vivo DCE MRI parameters correlated with ex vivo quantitative microvessel architecture: A radiohistomorphometric approach. Proc. SPIE 8676, Medical Imaging 2013: Digital Pathology, 867604 (March 29, 2013); doi:10.1117/12.2008136.
56. Chang H, Fontenay GV, Han J, et al. Morphometic analysis of TCGA glioblastoma multiforme. BMC Bioinformatics 2011;12:484.
57. Kong J, Cooper LA, Wang F, et al. Machine-based morphologic analysis of glioblastoma using whole-slide pathology images uncovers clinically relevant molecular correlates. PLoS One 2013;8:e81049.
58. Wang C, Pecot T, Zynger DL, et al. Identifying survival associated morphological features of triple negative breast cancer using multiple datasets. J Am Med Inform Assoc 2013;20:680-687.
59. Cooper LA, Kong J, Gutman DA, et al. Integrated morphologic analysis for the identification and characterization of disease subtypes. J Am Med Inform Assoc 2012;19:317-323.
60. Vincent P. Spatial Data Analysis by Example Point Pattern and Quantitative Data. In: Upton GJG, Fingleton B. Vol. 1, Wiley: Chichester, UK, 1990.
61. Smith CE, Hurley BJ, Toms CN, et al. Hurricane impacts on the foraging patterns of bottlenose dolphins Tursiops truncatus in Mississippi Sound. Mar Ecol Prog Ser 2013;487:231-244.